ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

Completed

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change certain substances (cells) found in the immune (protective) system. Blood test will be drawn by doing the following: * Use a new method called the "Immuknow®" Test to see if this method will help to better understand how MS medicines work. * Measure certain levels of immune cells in a new way, to see if it this will help to understand the body's response to MS medicines. These methods will test those with MS who are not taking any MS medications, to help us compare the results. About 100 subjects will be enrolled in this study at the Partners Multiple Sclerosis Center at Brigham and Women's Hospital. Biogen Idec, Inc. of Cambridge, MA, is paying for this study to be done.

Key facts

Study ID

NCT00618267

Run by

Biogen

People needed

100

Starts

2008-03-01

Expected to finish

2008-12-01

Last updated by the study team

2010-03-05

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be taking 1 of the following medications for 3 months or more: Cytoxan, Cellcept, Novantrone Betaseron, Rebif, Avonex or Copaxone.
• Patients must be able to provide written informed consent.

You may not qualify if…

• Patients on combination of multiple medications.
• Restricted treatment whereby no use in 50 days prior to enrollment visit is permitted: systemic steroids.
• With educational completion below 8th grade school equivalent or non-fluent in English.
• Any other reason, in the opinion of both the Investigator and/or Sponsor, the patient is determined not suitable for study participation.

Where it is running

• Brigham and Women's Hospital - Partners MS Center — Brookline, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.